Harbor Health Care ETF returns 15.30% in second-quarter 2026

Verifying
  • Harbor Health Care ETF returned 15.30% in the second quarter of 2026.
  • Biotechnology stocks led gains, supported by clinical data and merger activity.
  • Pharmaceutical stocks lagged as the ETF had lower exposure to Eli Lilly.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.